EUR 23.6
(1.72%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - EUR | 0.0% |
2022 | - EUR | 0.0% |
2021 | - EUR | 0.0% |
2020 | - EUR | -100.0% |
2019 | 1.00 EUR | -99.99% |
2018 | 7000.00 EUR | 0.0% |
2017 | - EUR | 100.0% |
2016 | -2.70 EUR | 0.0% |
2015 | - EUR | -100.0% |
2014 | 35.4 Million EUR | 13.08% |
2013 | 31.3 Million EUR | 33.77% |
2012 | 23.4 Million EUR | 9.26% |
2011 | 21.41 Million EUR | 53.3% |
2010 | 13.97 Million EUR | 114.42% |
2009 | 6.51 Million EUR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 1800.00 EUR | 0.0% |
2023 Q4 | - EUR | 0.0% |
2023 Q2 | - EUR | 0.0% |
2023 FY | - EUR | 0.0% |
2022 Q2 | 1620.00 EUR | 0.0% |
2022 Q4 | - EUR | 0.0% |
2022 FY | - EUR | 0.0% |
2021 Q4 | - EUR | 0.0% |
2021 Q2 | 1710.00 EUR | 0.0% |
2021 FY | - EUR | 0.0% |
2020 Q2 | 1911.96 EUR | 0.0% |
2020 FY | - EUR | -100.0% |
2020 Q4 | - EUR | 0.0% |
2019 FY | 1.00 EUR | -99.99% |
2019 Q4 | 1.00 EUR | 0.0% |
2019 Q2 | 8934.75 EUR | 0.0% |
2018 Q4 | 7000.00 EUR | 0.0% |
2018 FY | 7000.00 EUR | 0.0% |
2018 Q2 | - EUR | 0.0% |
2017 Q4 | - EUR | 0.0% |
2017 Q2 | - EUR | 0.0% |
2017 FY | - EUR | 100.0% |
2016 FY | -2.70 EUR | 0.0% |
2016 Q2 | - EUR | 0.0% |
2016 Q4 | - EUR | 0.0% |
2015 Q4 | - EUR | 0.0% |
2015 FY | - EUR | -100.0% |
2015 Q2 | 47.87 Million EUR | 0.0% |
2014 Q4 | 35.4 Million EUR | 0.0% |
2014 FY | 35.4 Million EUR | 13.08% |
2014 Q2 | 37.06 Million EUR | 0.0% |
2013 Q4 | 31.3 Million EUR | 0.0% |
2013 FY | 31.3 Million EUR | 33.77% |
2013 Q2 | 27.23 Million EUR | 0.0% |
2012 Q3 | 23.4 Million EUR | -36.47% |
2012 Q1 | 36.83 Million EUR | 71.98% |
2012 FY | 23.4 Million EUR | 9.26% |
2012 Q2 | 36.83 Million EUR | 0.0% |
2012 Q4 | 23.4 Million EUR | 0.0% |
2011 FY | 21.41 Million EUR | 53.3% |
2011 Q4 | 21.41 Million EUR | 0.0% |
2011 Q2 | 17.27 Million EUR | 0.0% |
2010 Q4 | 13.97 Million EUR | 0.0% |
2010 FY | 13.97 Million EUR | 114.42% |
2009 FY | 6.51 Million EUR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Apontis Pharma AG | 6.6 Million EUR | 100.0% |
Dermapharm Holding SE | 320.75 Million EUR | 100.0% |
Evotec SE | 30.89 Million EUR | 100.0% |
MERCK Kommanditgesellschaft auf Aktien | 4.63 Billion EUR | 100.0% |
PharmaSGP Holding SE | 10.11 Million EUR | 100.0% |
SynBiotic SE | 2.76 Million EUR | 100.0% |